Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Medtech mergers stayed strong in Q3
Ortho Spine News
Saturday, November 15, 2014 - 9:55am
tags:
M&A
Merck Serono Plans to Make China Leader in Oncology Treatment
Yibada, China
Saturday, November 15, 2014 - 9:53am
tags:
Merck Serono, China
DOJ Investigation into Generic Pharmaceutical Pricing Signals Potential Criminal Exposure
law.com
Saturday, November 15, 2014 - 9:46am
tags:
generics, legal
Geron Collaborates with J&J for Imetelstat
Yahoo/Zacks
Saturday, November 15, 2014 - 9:42am
tags:
Geron, JNJ, imetelstat, myelofibrosis, acute myelogenous leukemia, myelodysplastic syndrome, leukemia
Genzyme’s Lemtrada Approved by the FDA
Yahoo/Businesswire
Saturday, November 15, 2014 - 9:34am
tags:
Genzyme, Lemtrada, multiple sclerosis, MS
Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update
Yahoo/PR NewsWire
Saturday, November 15, 2014 - 9:32am
tags:
Anthera Pharmaceuticals, earnings
Isis/AstraZeneca Expand Antisense Technology Collaboration
Yahoo/Zacks
Saturday, November 15, 2014 - 9:30am
tags:
AstraZeneca, Isis Pharmaceuticals, antisense, ISIS-STAT3Rx, hepatocellular carcinoma, prostate cancer, ISIS-ARRx
Federal judge has unsealed details in lawsuit filed by the city of Chicago against five makers of opioid painkillers
Bloomberg/Businessweek
Friday, November 14, 2014 - 11:07am
tags:
opioids, painkillers, chicago, Cephalon, Janssen, Endo Health Solutions, Teva Pharmaceutical
Boehringer taps WellPoint's outcomes data to develop new a-fib drugs
Fierce Biotech
Friday, November 14, 2014 - 11:03am
tags:
Boehringer Ingelheim, Wellpoint, atrial fibrillation, R&D, clinical outcomes
Johnson & Johnson (JNJ) Wins Label Expansion Approval For Antipsychotic Drug
Bidness Etc.
Friday, November 14, 2014 - 11:01am
tags:
JNJ, Janssen, antipsychotics, Invega Sustenna, schizophrenia
2015 an "important year" for Pfizer's IO pipeline, analysts say
Medical Marketing and Media
Friday, November 14, 2014 - 10:59am
tags:
Pfizer, immunotherapy
Belviq For Smoking Cessation - Sizzle Or Smolder?
Seeking Alpha
Friday, November 14, 2014 - 10:55am
tags:
Belviq, smoking cessation
AstraZeneca not only game in town for deal-hungry Pfizer
Yahoo/Reuters
Friday, November 14, 2014 - 10:47am
tags:
AstraZeneca, Pfizer, M&A, Actavis
Alnylam reports results from Phase 2 revusiran trial
Seeking Alpha
Friday, November 14, 2014 - 9:54am
tags:
Alnylam, revusiran, TTR cardiac amyloidosis, RNAi
Why are M&A hedge funds gun shy? Blame AbbVie for killing its Shire deal
Fierce Pharma
Friday, November 14, 2014 - 9:53am
tags:
M&A, AbbVie, Shire
Can Gilead Double From Here?
Forbes
Friday, November 14, 2014 - 9:51am
tags:
Gilead Sciences
FDA approves 2 new Allergan breast implants
Mass Device
Friday, November 14, 2014 - 9:49am
tags:
FDA, devices, Allergan, breast implants
Physicians Continue to Voice Strong Support for Allergan via Open Letters to the Eye Care Community
Yahoo
Friday, November 14, 2014 - 9:29am
tags:
physicians, Allergan, M&A, Valeant Pharmaceuticals
Valeant Should Drop Allergan Bid And Go For Zoetis
Seeking Alpha
Friday, November 14, 2014 - 8:43am
tags:
Valeant Pharmaceuticals, Allergan, Zoetis, M&A
Can Actavis Break The Siege Of Allergan?
Forbes
Friday, November 14, 2014 - 8:27am
tags:
Actavis, Allergan, Valeant Pharmaceuticals, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.